Mates Sharon
- SEC CIK
- 0001585699
No open-market purchases or sales filed in the past year.
Current role at each company
- SPTX Seaport Therapeutics, Inc.Directoras of May 4, 2026
- BNTC Benitec Biopharma Inc.Directoras of Jan 26, 2026
- ITCI Intra-Cellular Therapies, Inc.Chairman and CEOas of Apr 2, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mates Sharon as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ITCI Intra-Cellular Therapies, Inc.
Chairman and CEO17 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 18, 2021 (view filing) | Oct 14-18 | 4 days | Mates SharonChairman, President & CEO | SSale | −50.0K | $40.00 | −$2.00M | −4.4%1.09M after | 3 lots |
| Jan 11, 2022 (view filing) | Jan 10 | 1 day | Mates SharonChairman, President & CEO | SSale | −41.9K | $40.78 | −$1.71M | −3.7%1.09M after | 3 lots |
| Feb 23, 2022 (view filing) | Feb 22 | 1 day | Mates SharonChairman, President & CEO | SSale | −27.8K | $55.39 | −$1.54M | −2.5%1.09M after | 2 lots |
| Feb 25, 2022 (view filing) | Feb 24 | 1 day | Mates SharonChairman, President & CEO | SSale | −22.6K | $51.98 | −$1.17M | −2.0%1.09M after | 3 lots |
| Dec 15, 2022 (view filing) | Dec 13 | 2 days | Mates SharonChairman, President & CEO | SSale | −33.1K | $55.00 | −$1.82M | −2.9%1.10M after | |
| Feb 22, 2023 (view filing) | Feb 21 | 1 day | Mates SharonChairman, President & CEO | SSale | −27.8K | $46.83 | −$1.30M | −2.5%1.10M after | 4 lots |
| Feb 27, 2023 (view filing) | Feb 24 | 3 days | Mates SharonChairman, President & CEO | SSale | −22.6K | $47.03 | −$1.06M | −2.0%1.10M after | |
| Mar 13, 2023 (view filing) | Mar 10-13 | 3 days | Mates SharonChairman, President & CEO | SSale | −62.3K | $43.76 | −$2.73M | −5.2%1.13M after | 4 lots |
| Sep 19, 2023 (view filing) | Sep 18-19 | 1 day | Mates SharonChairman, President & CEO | SSale | −100.0K | $53.94 | −$5.39M | −8.7%1.05M after | 3 lots10b5-1 |
| Jan 18, 2024 (view filing) | Jan 16-18 | 2 days | Mates SharonChairman, President & CEO | SSale | −191.4K | $66.27 | −$12.7M | −15.4%1.05M after | 7 lots10b5-1 |